Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gao, Jimin
NCT04324996: A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19	Recruiting	1/2	90	RoW	NK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2 CAR-NK cells,NKG2D-ACE2 CAR-NK cells	Chongqing Public Health Medical Center, Chongqing Sidemu Biotech, Zhejiang Qixin Biotech	COVID-19	02/22	08/22
NCT03932565: Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors	Recruiting	1	30	RoW	CAR-T therapy for nectin4-positive malignant solid tumor	The Sixth Affiliated Hospital of Wenzhou Medical University, Zhejiang Qixin Biotech	Nectin4-positive Advanced Malignant Solid Tumor	06/21	12/21
NCT03778346: Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation of CAR-T Cells	Recruiting	1	30	RoW	CAR-T therapy in Relapsed/Refractory multiple myeloma	The Sixth Affiliated Hospital of Wenzhou Medical University, Zhejiang Qixin Biotech	RRMM	06/22	12/22
Zhao, Ai
NCT03932565: Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors	Recruiting	1	30	RoW	CAR-T therapy for nectin4-positive malignant solid tumor	The Sixth Affiliated Hospital of Wenzhou Medical University, Zhejiang Qixin Biotech	Nectin4-positive Advanced Malignant Solid Tumor	06/21	12/21
NCT03778346: Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation of CAR-T Cells	Recruiting	1	30	RoW	CAR-T therapy in Relapsed/Refractory multiple myeloma	The Sixth Affiliated Hospital of Wenzhou Medical University, Zhejiang Qixin Biotech	RRMM	06/22	12/22
NCT05987384: The Role of Fatty Acids in Vaccine Efficacy	Completed	N/A	45	RoW	Arachidonic acid, Sunflower oil, Rabies Vaccine (Vero Cell) for Human Use	Tsinghua University	Rabies Vaccination Reaction	07/23	07/23